Duration of viral shedding and culture positivity with postvaccination SARSCoV-2 delta variant infections

Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection...

Full description

Bibliographic Details
Main Authors: Barczak, A.K (Author), Boucau, J. (Author), Chamberlin, G.C (Author), Choudhary, M.C (Author), Flynn, J.P (Author), Gilbert, R.F (Author), Goldstein, R.H (Author), Haneuse, S. (Author), Iyer, S. (Author), Lemieux, J.E (Author), Li, J.Z (Author), Luu, J. (Author), North, C.M (Author), Regan, J. (Author), Reynolds, Z. (Author), Sacks, C.A (Author), Siedner, M.J (Author), Uddin, R. (Author), Vyas, J.M (Author), Vyas, T. (Author)
Format: Article
Language:English
Published: American Society for Clinical Investigation 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03959nam a2200853Ia 4500
001 10-1172-jci-insight-155483
008 220420s2022 CNT 000 0 und d
020 |a 23793708 (ISSN) 
245 1 0 |a Duration of viral shedding and culture positivity with postvaccination SARSCoV-2 delta variant infections 
260 0 |b American Society for Clinical Investigation  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1172/jci.insight.155483 
520 3 |a Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections. Copyright: © 2022, Siedner et al. 
650 0 4 |a administration and dosage 
650 0 4 |a adult 
650 0 4 |a Adult 
650 0 4 |a Article 
650 0 4 |a clinical article 
650 0 4 |a cohort analysis 
650 0 4 |a coronavirus disease 2019 
650 0 4 |a COVID-19 
650 0 4 |a COVID-19 Vaccines 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a genetics 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a isolation 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a metabolism 
650 0 4 |a middle aged 
650 0 4 |a Middle Aged 
650 0 4 |a nonhuman 
650 0 4 |a nose smear 
650 0 4 |a physiology 
650 0 4 |a polymerase chain reaction 
650 0 4 |a practice guideline 
650 0 4 |a prevention and control 
650 0 4 |a SARS-CoV-2 
650 0 4 |a SARS-CoV-2 Delta 
650 0 4 |a symptom 
650 0 4 |a time factor 
650 0 4 |a Time Factors 
650 0 4 |a vaccination 
650 0 4 |a virus culture 
650 0 4 |a virus load 
650 0 4 |a virus replication 
650 0 4 |a virus replication 
650 0 4 |a Virus Replication 
650 0 4 |a virus shedding 
650 0 4 |a virus shedding 
650 0 4 |a Virus Shedding 
650 0 4 |a whole genome sequencing 
700 1 0 |a Barczak, A.K.  |e author 
700 1 0 |a Boucau, J.  |e author 
700 1 0 |a Chamberlin, G.C.  |e author 
700 1 0 |a Choudhary, M.C.  |e author 
700 1 0 |a Flynn, J.P.  |e author 
700 1 0 |a Gilbert, R.F.  |e author 
700 1 0 |a Goldstein, R.H.  |e author 
700 1 0 |a Haneuse, S.  |e author 
700 1 0 |a Iyer, S.  |e author 
700 1 0 |a Lemieux, J.E.  |e author 
700 1 0 |a Li, J.Z.  |e author 
700 1 0 |a Luu, J.  |e author 
700 1 0 |a North, C.M.  |e author 
700 1 0 |a Regan, J.  |e author 
700 1 0 |a Reynolds, Z.  |e author 
700 1 0 |a Sacks, C.A.  |e author 
700 1 0 |a Siedner, M.J.  |e author 
700 1 0 |a Uddin, R.  |e author 
700 1 0 |a Vyas, J.M.  |e author 
700 1 0 |a Vyas, T.  |e author 
773 |t JCI Insight